Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
06/2010
06/16/2010CN101735306A Anti-inflammatory peptide with membrane penetration effect
06/16/2010CN101735305A Synthesizing method of L-carnosine
06/15/2010US7737114 macrocyclic depsipeptides, for use as anticancer agents and an inhibitors of protein synthesis, cell growth, and tumorigenesis and as enhancers of apoptosis
06/15/2010US7737113 Cyclic and linear oligopeptides; capable of increasing gap junction conductance; lack the proarrhythmic side effects; use as drug to also treat eye disorders, cancer, and gastrointestinal disorders among others
06/15/2010US7737111 Tumor necrosis factors; cytokines; immunoglobulins; autoimmune diseases
06/15/2010US7736654 Proteins, polynucleotides, antibodies, transgenic animals, hybridoma; humoral or cellular immune response; pancreatic
06/15/2010CA2299495C Process for preparing growth hormone secretagogues
06/10/2010WO2010065577A1 Hepatitis c virus inhibitors
06/10/2010WO2010065362A1 Improvements in polypeptide synthesis for drug delivery
06/10/2010WO2009115658A3 Use of a caspase-1 inhibitor for treating atherosclerotic plaque
06/10/2010US20100145071 Small molecule inhibitors of rotamase enzyme activity
06/10/2010US20100145013 Process for preparing (1r,2s,5s)-n-[(1s)-3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[(2s)-2-[[[(1,1-dimethylethyl)amino]-carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide
06/10/2010US20100144649 Compounds for enzyme inhibition
06/10/2010US20100144637 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
06/09/2010EP2194383A1 Monitoring immunologic, hematologic and inflammatory diseases
06/09/2010EP2194061A1 HC-Toxin as means for treating advanced stage neuroblastoma
06/09/2010EP1730110B1 Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease
06/09/2010CN101724018A 2-(2-methacrylamide triglycyl) aminomalonate ester as well as preparation method and application thereof
06/09/2010CN101724017A 4-nitro-L-phenylalanine dipeptide derivatives as well as preparation method and applications thereof
06/09/2010CN101724016A Peptide compound and preparation method and application thereof
06/09/2010CN101721676A Gene regulatory peptides
06/08/2010US7732566 a protein originating from latex that can induce an allergic reaction in persons sensitized to the protein
06/08/2010US7732564 Serum tumor marker in rodent prostate cancer models
06/08/2010US7731995 Methods for using soy peptides to inhibit H3 acetylation, reduce expression of HMG CoA reductase, and increase LDL receptor and Sp1 expression in a mammal
06/08/2010US7731970 Variants of the major allergen Phl p 1 from timothy grass
06/03/2010WO2010061902A1 Screening method, composition containing substance selected by the screening method, and binding substance
06/03/2010WO2010061787A1 Beauveriolide having acat-2 inhibitory activity
06/03/2010US20100137583 Peptidomimetic protease inhibitors
06/03/2010US20100137561 Process for preparing therapeutic peptide
06/03/2010US20100137227 Methods and compositions for treating conditions
06/03/2010US20100137221 Peptides that interact with topoisomerase i and methods thereof
06/03/2010US20100137196 Histone deacetylases, and uses related thereto
06/03/2010US20100136626 Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific Antibodies
06/03/2010US20100136197 Kokumi- imparting agent
06/03/2010US20100135941 Skin-whitening agent
06/02/2010EP2190858A2 Urea-containing peptides as inhibitors of viral replication
06/02/2010EP1924593B9 Hcv ns3 protease inhibitors
06/02/2010EP1534736B1 Nogo receptor antagonists
06/02/2010EP1481000B1 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
06/02/2010CN1946743B Hyaluronic acid/methotrexate compound
06/02/2010CN1291231B Human telomerase catalytic subunit
06/01/2010US7728000 compounds which intercalate between DNA base pairs, resulting in an interruption of transcription, replication and/or topoisomerase activity; antiproliferative and antitumor agents
06/01/2010US7727964 Peptides substituted with a functional group that reacts with an active site residue of the targeted protease, e.g., Cyclohexylglycine BoroAla, and compounds that can hydrolyzed to produce them; improved specificity for regulating glucose metabolism
06/01/2010US7727956 Deoxonadepsipeptides
06/01/2010CA2442679C Methods for secretory production of proteins
05/2010
05/27/2010WO2010059937A1 Cyclic carboxamide compounds and analogues thereof as of hepatitis c virus
05/27/2010WO2010059051A2 Rapid fret based pathogen diagnosis
05/27/2010WO2010058419A1 Tumor necrosis factor alpha inhibiting peptides and uses thereof
05/27/2010US20100130722 Polymeric carrier for delivery of small interfering rna
05/27/2010CA2744365A1 Tumor necrosis factor alpha inhibiting peptides and uses thereof
05/27/2010CA2743912A1 Cyclic carboxamide compounds and analogues thereof as of hepatitis c virus
05/26/2010EP2189536A1 Rapid FRET based anthrax diagnosis
05/26/2010EP2189156A1 Lys-Pro and Lys-Pro-Thr for the manufacture of a cosmetic composition
05/26/2010EP2188254A1 Novel bradykinin b1-antagonists
05/26/2010EP1572168B1 Anti-infarction molecules
05/26/2010CN1359390B Factor VII a inhibitors
05/26/2010CN101715484A Method for producing dipeptide
05/26/2010CN101712688A Hybrid QA molecules wherein Q is an aminoquinoline and A is an antibiotic residue, their synthesis and their uses as antibacterial agent
05/25/2010USRE41356 Hepatitis C inhibitor tri-peptides
05/25/2010US7723477 Frizzled receptor specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders
05/25/2010US7723472 Fusion polypeptide comprising a hyaluronan-binding polypeptide fused to a heterologous polypeptide such as a growth factor, an enzyme that activates a prodrug, an angiogenesis inhibitor, a chemoattractant polypeptide or a matrix metalloproteinase inhibitor; anticancer agents
05/25/2010US7723469 Treating leukemia by administering a cross-linked polypeptide antiapoptosis agent having at least two modified amino acids ("hydrocarbon stapling"); crosslinking increases cell permeability
05/25/2010US7723307 transglutaminase inhibitor; fibrosis, scarring, neurodegenerative diseases, autoimmune diseases, thrombosis, proliferative disorders, AIDS, psoriasis, inflammation; N-Benzyloxycarbonyl-L-phenylalanyl-6-dimethylsulfonium-5-oxo-L-norleucine; 6-diazo-5-oxo-L-norleucine reacted with N-protected amino acid
05/25/2010US7723295 Peptides and compounds that bind to a receptor
05/25/2010CA2173130E Glutathione s-transferase-activated compounds
05/20/2010WO2010056496A1 Azepinone derivatives
05/20/2010WO2010055500A1 A vaccinia virus protein a46 peptide and use thereof
05/20/2010WO2010055135A1 Process for the purification of human growth hormone polypeptides using affinity resins comprising specific ligands
05/20/2010WO2010055052A1 Detergent composition
05/20/2010WO2010054528A1 Quinazoline compounds
05/20/2010WO2009083663A8 Cyclic peptides comprising at least one aza-β3-aminoacyl residue and uses thereof
05/20/2010US20100125127 Activation antigen expressed on B-cells for treating conditions associated with aberrant or increased T-cell proliferation
05/20/2010US20100124545 Cyclic carboxamide compounds and analogues thereof as of hepatitis c virus
05/20/2010CA2780624A1 Isoprenyl compounds and methods thereof
05/20/2010CA2744120A1 A vaccinia virus protein a46 peptide and use thereof
05/20/2010CA2743145A1 Azepinone derivatives
05/19/2010CN101709078A immune-modulating peptide
05/19/2010CN101709077A Method for crudely extracting saccharomyces cerevisiae glutathione
05/18/2010US7718772 Canine thymic stromal lymphopoietin protein and uses thereof
05/18/2010US7718769 Tri-peptide hepatitis C serine protease inhibitors
05/18/2010US7718768 Biologically active peptide PTTKTYFPHF
05/18/2010US7718764 Biologically active peptide VAPEEHPTLLTEAPLNPK derivatives
05/18/2010US7718762 stimulate T cytotoxic lymphocytes in a mammal
05/18/2010US7718691 3-Azabicyclo[3.1.0]hexane-amide derivatives; human T-cell leukemia/lymphoma and lymphadenopathy associated virus, AIDS, cytomegalovirus (CMV) and Epstein-Barr virus (EBV), liver disease such as alcoholism and primary biliar cirrhosis
05/18/2010US7718620 Methods for preventing or treating ischemia-reperfusion injury of the kidney
05/18/2010US7718617 Using tissue preservation solution ( kallikrein inhibitor ) to decrease reperfusion injury of an organ during surgery and/or following removal of organ
05/18/2010US7718612 Pyridazinonyl macrocyclic hepatitis C serine protease inhibitors
05/18/2010US7718600 IAP binding compounds
05/18/2010US7718406 benzoyl-(L)-lysyl-( epsilon -benzyloxycarbonyl)- alpha -(D,L)-(2-guanidinoethylthio)-glycine hydrochloride salt ; substrate for the detection of TAFIa (thrombin-activatable fibrinolysis inhibitor) , a fibrinolysis inhibiting enzyme
05/14/2010WO2010054102A2 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof
05/14/2010CA2742782A1 Endothelium mimicking nanomatrix
05/13/2010US20100120699 Method for synthesizing kpv tripeptide diamide derivates
05/13/2010US20100120126 Microorganisms producing dipeptides and process for producing dipeptide using the microorganisms
05/12/2010EP2184291A1 Binding polypeptides for B lymphocyte stimulator protein (BLyS)
05/12/2010EP2184290A1 Method for producing peptide
05/12/2010EP2183279A1 Method for selectively modifying a protein
05/12/2010CN1972960B Processes for preparing eptifibatide
05/12/2010CN1646558B Histone deacetylase inhibitors and process for producing the same
05/12/2010CN101704878A Polypeptide derivatives for generating stable micro-molecular hydrogel
05/12/2010CN101045744B Anti-titanium oxide from collagen and its use
1 ... 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... 307